Jul 12, 2023
Archives: News
Jan 13, 2022
Salarius Expands Oncology Pipeline Through Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC
Aug 11, 2021
David Arthur, Salarius CEO Speaks with Dan Sfera of The Clinical Trials Guru
Aug 4, 2020
Salarius Pharmaceuticals raises millions for expanded clinical trial, moves office in TMC
Jun 19, 2020
15 Biotech Companies in Houston Making a Major Impact on Medicine
Apr 7, 2020
Targeting Epigenetic Causes of Ewing’s Sarcoma with David Arthur Salarius Pharmaceuticals on Empowered Patient Podcast with Karen Jagoda
Jan 15, 2020
Salarius During the JP Morgan Week – Attend the Biotech Showcase Presentation or Join the Live Webcast
Jan 14, 2020
Salarius Pharmaceuticals CEO talks through recent achievements for its lead cancer drug candidate
Jan 9, 2020
Scrip Asks…What Does 2020 Hold For Biopharma? Part 3: Policy And Regulation
Dec 11, 2019